Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2003 Dec;7(6):420-1.
doi: 10.1186/cc2403. Epub 2003 Nov 6.

Nondrug costs of therapy in acute care--are they important?

David L Edbrooke  1 , Richard S Bourne
Affiliations
Comment

Nondrug costs of therapy in acute care--are they important?

David L Edbrooke et al. Crit Care. 2003 Dec.

Abstract

Drug acquisition costs are only a proportion of the total costs associated with drug therapy. The relevance of these costs are often not appreciated. However, they impact on the Intensive Care Unit via resources and quality of care. Increased indirect care by medical and nursing staff has the potential to adversely affect patient outcome. Redirecting staff to their primary role and reducing indirect patient activities will increase quality and allow more patients to be treated. Costs and resources are increasingly important in health care provision.

PubMed Disclaimer

Comment on

References

    1. van Zanten ARH, Engelfriet PM, van Dillen K, van Veen M, Nuijten MJC, Polderman KH. Importance of nondrug costs of intravenous antibiotic therapy. Crit Care. 2003;7:R184–R190. doi: 10.1186/cc2388. - DOI - PMC - PubMed
    1. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ, Jr, Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699–709. doi: 10.1056/NEJM200103083441001. - DOI - PubMed
    1. Angus DC, Linde-Zwirble WT, Clermont G, Ball DE, Basson BR, Ely EW, Laterre PF, Vincent JL, Bernard G, van Hout B, PROWESS Investigators Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis. Crit Care Med. 2003;31:1–11. - PubMed
    1. Manns BJ, Lee H, Doig CJ, Johnson D, Donaldson C. An economic evaluation of activated protein C treatment for severe sepsis. N Engl J Med. 2002;347:993–1000. doi: 10.1056/NEJMsa020969. - DOI - PubMed
    1. Adal KA, Anglim AM, Palumbo CL, Titus MG, Coyner BJ, Farr BM. The use of high-efficiency particulate air-filter respirators to protect hospital workers from tuberculosis. A cost-effectiveness analysis. N Engl J Med. 1994;331:169–173. doi: 10.1056/NEJM199407213310306. - DOI - PubMed

MeSH terms

Substances